Literature DB >> 6405345

Autoimmune reactivity in Cogan's syndrome: a preliminary report.

G B Hughes, S E Kinney, B P Barna, R L Tomsak, L H Calabrese.   

Abstract

Autoimmune inner ear disease was first described by McCabe in 1979. The diagnosis is supported by cell-mediated immune responses to inner ear membrane antigen stimulation. Cogan's syndrome consists of vestibuloauditory dysfunction, ocular inflammation, and nonreactive serologic tests for syphilis. The ocular disease can be controlled by steroids; unfortunately, some patients ultimately become totally deaf. An autoimmune etiology has long been suspected but only recently confirmed by McCabe. In our study two patients with Cogan's syndrome were studied for autoimmune inner ear disease with the use of both cellular and humoral immune tests. Results were compared to normal control subjects. On the basis of test results, preliminary conclusions were that (1) the vestibuloauditory symptoms of Cogan's syndrome are autoimmune in origin; (2) the autoimmune process is mediated through cellular rather than humoral (antibody) pathways; (3) systemic steroids may suppress positive test results; and (4) test results are more likely to be positive when symptoms are acute. Therapeutic implications are significant: the addition of cytotoxic drugs to steroids in selected cases may help prevent total deafness that otherwise might be inevitable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405345     DOI: 10.1177/019459988309100106

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

1.  Cogan's syndrome: an oculo-audiovestibular disease.

Authors:  J R García Berrocal; J A Vargas; M Vaquero; S Ramón y Cajal; R A Ramírez-Camacho
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

2.  Serum antibodies against membranous labyrinth in patients with "idiopathic" bilateral vestibulopathy.

Authors:  V Arbusow; M Strupp; M Dieterich; W Stöcker; A Naumann; P Schulz; T Brandt
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

Review 3.  Cogan's syndrome and other ocular vasculitides.

Authors:  Gabriela M Espinoza; Angela Prost
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

4.  Association of Crohn's disease and Cogan's syndrome.

Authors:  F Froehlich; M Fried; J J Gonvers; E Saraga; J Thorens; A Pecoud
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

Review 5.  Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms.

Authors:  Francesca Yoshie Russo; Massimo Ralli; Daniele De Seta; Patrizia Mancini; Alessandro Lambiase; Marco Artico; Marco de Vincentiis; Antonio Greco
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

6.  Immune status in patients with Menière's disease.

Authors:  K L Evans; D L Baldwin; D Bainbridge; A W Morrison
Journal:  Arch Otorhinolaryngol       Date:  1988

Review 7.  Biological and clinical aspects of autoimmune inner ear disease.

Authors:  A J Griffith
Journal:  Yale J Biol Med       Date:  1992 Jan-Feb

8.  Immune complex-associated deafness: preliminary communication.

Authors:  G B Brookes
Journal:  J R Soc Med       Date:  1985-01       Impact factor: 18.000

Review 9.  Optimal management of Cogan's syndrome: a multidisciplinary approach.

Authors:  Vittorio D'Aguanno; Massimo Ralli; Marco de Vincentiis; Antonio Greco
Journal:  J Multidiscip Healthc       Date:  2017-12-22

10.  Cochlear implant in Cogan's syndrome.

Authors:  Rajesh Vishwakarma; T Joseph Shawn
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-17       Impact factor: 3.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.